Aspira Pathlab & Diagnostics Limited (BOM:540788)
131.00
-4.65 (-3.43%)
At close: Nov 20, 2026
BOM:540788 Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 19, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 1,348 | 575 | 877 | 319 | 287 | 667 | |
Market Cap Growth | 103.10% | -34.47% | 174.94% | 11.31% | -57.02% | 127.37% |
Enterprise Value | 1,386 | 587 | 878 | 329 | 285 | 685 |
Last Close Price | 131.00 | 55.85 | 85.23 | 31.00 | 27.85 | 64.80 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 19, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | 1120.59 | 42.33 | - | - | 14.96 |
PS Ratio | 5.60 | 2.30 | 3.99 | 2.42 | 1.98 | 3.41 |
PB Ratio | 12.22 | 4.70 | 7.18 | 3.15 | 2.25 | 5.22 |
P/TBV Ratio | 17.85 | 14.44 | 18.99 | 12.54 | 5.59 | 13.05 |
P/FCF Ratio | 148.42 | 75.84 | 57.24 | 40.31 | - | 46.56 |
P/OCF Ratio | 64.07 | 39.55 | 46.74 | 30.29 | - | 32.84 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 19, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 5.76 | 2.35 | 3.99 | 2.49 | 1.97 | 3.51 |
EV/EBITDA Ratio | - | 95.05 | 31.14 | - | 35.26 | 12.07 |
EV/EBIT Ratio | - | - | 42.55 | - | 3700.96 | 14.46 |
EV/FCF Ratio | 152.57 | 77.47 | 57.28 | 41.53 | - | 47.84 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 19, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.41 | 0.27 | 0.26 | 0.27 | 0.26 | 0.31 |
Debt / EBITDA Ratio | - | 2.27 | 0.90 | - | 2.16 | 0.62 |
Debt / FCF Ratio | 4.99 | 4.38 | 2.09 | 3.52 | - | 2.74 |
Net Debt / Equity Ratio | 0.34 | 0.13 | 0.09 | 0.14 | 0.08 | 0.18 |
Net Debt / EBITDA Ratio | -1.38 | 2.66 | 0.37 | -0.73 | 1.19 | 0.40 |
Net Debt / FCF Ratio | 4.15 | 2.17 | 0.69 | 1.77 | -6.73 | 1.59 |
Asset Turnover | 1.22 | 1.39 | 1.37 | 0.82 | 0.82 | 1.31 |
Inventory Turnover | 21.53 | 24.81 | 25.64 | 23.14 | 22.06 | 24.80 |
Quick Ratio | 1.05 | 1.11 | 1.90 | 1.76 | 2.97 | 3.44 |
Current Ratio | 1.43 | 1.47 | 2.26 | 2.10 | 3.70 | 3.99 |
Return on Equity (ROE) | -27.11% | 0.42% | 18.54% | -23.34% | -0.69% | 42.26% |
Return on Assets (ROA) | -11.17% | -0.26% | 8.00% | -10.63% | 0.03% | 19.80% |
Return on Invested Capital (ROIC) | -24.56% | -0.55% | 16.63% | -21.58% | 0.05% | 39.03% |
Return on Capital Employed (ROCE) | -22.60% | -0.50% | 13.60% | -21.60% | 0.00% | 29.00% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 19, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | -2.56% | 0.09% | 2.36% | -8.38% | -0.31% | 6.69% |
FCF Yield | 0.67% | 1.32% | 1.75% | 2.48% | -0.50% | 2.15% |
Buyback Yield / Dilution | 1.87% | - | - | - | - | -8.12% |